524156 TCMLMTD

TCM Share Price

 

 

Start SIP in TCMLMTD

Start SIP

Performance

  • Low
  • ₹62
  • High
  • ₹64
  • 52 Week Low
  • ₹35
  • 52 Week High
  • ₹81
  • Open Price₹64
  • Previous Close₹64
  • Volume990

Investment Returns

  • Over 1 Month -9.62%
  • Over 3 Month + 47.96%
  • Over 6 Month + 55%
  • Over 1 Year + 29.6%

Smart Investing Starts Here Start SIP with TCM for Steady Growth!

Invest Now

TCM Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 336.6
  • PEG Ratio
  • 3
  • Market Cap Cr
  • 48
  • P/B Ratio
  • 1.7
  • Average True Range
  • 3.57
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.06
  • RSI
  • 48.37
  • MFI
  • 39.84

TCM Financials

TCM Technicals

EMA & SMA

Current Price
₹63.92
-0.22 (-0.34%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹64.63
  • 50 Day
  • ₹61.96
  • 100 Day
  • ₹56.36
  • 200 Day
  • ₹51.32

Resistance and Support

63.28 Pivot Speed
  • R3 66.48
  • R2 65.20
  • R1 64.56
  • S1 62.64
  • S2 61.36
  • S3 60.72

TCM Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-11 Quarterly Results
2025-08-11 Quarterly Results
2025-05-29 Audited Results
2025-02-10 Quarterly Results & Others To consider other business matters. issue of equity shares of Rs. 10/- each in the ratio of 6:5 @ premium of Rs. 15/-.
2024-11-12 Quarterly Results

TCM F&O

TCM Shareholding Pattern

49.51%
7.41%
38.79%
4.29%

TCM FAQs

TCM share price is ₹63 As on 01 January, 2026 | 22:34

The Market Cap of TCM is ₹47.8 Cr As on 01 January, 2026 | 22:34

The P/E ratio of TCM is 336.6 As on 01 January, 2026 | 22:34

The PB ratio of TCM is 1.7 As on 01 January, 2026 | 22:34

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23